TR200001761T2 - Çoklu terapilerde aktif esasların tatbiki için bir çift kapsül. - Google Patents

Çoklu terapilerde aktif esasların tatbiki için bir çift kapsül.

Info

Publication number
TR200001761T2
TR200001761T2 TR2000/01761T TR200001761T TR200001761T2 TR 200001761 T2 TR200001761 T2 TR 200001761T2 TR 2000/01761 T TR2000/01761 T TR 2000/01761T TR 200001761 T TR200001761 T TR 200001761T TR 200001761 T2 TR200001761 T2 TR 200001761T2
Authority
TR
Turkey
Prior art keywords
active ingredients
capsule
dosage form
pharmaceutical dosage
capsules
Prior art date
Application number
TR2000/01761T
Other languages
English (en)
Inventor
Sanso Giovanni
Original Assignee
Axcan Pharma Inc.
Istituto Pirri S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11378381&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200001761(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Axcan Pharma Inc., Istituto Pirri S.R.L. filed Critical Axcan Pharma Inc.
Publication of TR200001761T2 publication Critical patent/TR200001761T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Aktif maddelerin çoklu terapiler halinde uygulanmasina çok uygun farmasötik bir doz biçimi açiklanmaktadir. Farmasötik doz biçimi iç kapsülün dis kapsül içine yerlestirildigi ikili bir kapsüldür. Her bir iç ve dis kapsül bir ya da daha fazla aktif madde içerir. Bulusa göre ikili kapsül tercihen Helicobacter Pylori mikroorganizmalarina karsi üçlü ya da dörtlü terapilerde kullanilir. Bu farmasötik doz biçiminin avantajlari iki ya da daha fazla aktif maddenin uygulanmasi için basit bir pozlandirma sunmasi ve aktif maddelerin dogru zaman araliklarinda ve önceden belirlenmis miktarlarda etkinlesmesine olanak tanimasi ve aktif maddeler arasinda etkilesimleri önlemesidir.
TR2000/01761T 1997-12-17 1998-12-14 Çoklu terapilerde aktif esasların tatbiki için bir çift kapsül. TR200001761T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI002788A IT1296980B1 (it) 1997-12-17 1997-12-17 Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple

Publications (1)

Publication Number Publication Date
TR200001761T2 true TR200001761T2 (tr) 2000-10-23

Family

ID=11378381

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01761T TR200001761T2 (tr) 1997-12-17 1998-12-14 Çoklu terapilerde aktif esasların tatbiki için bir çift kapsül.

Country Status (26)

Country Link
US (1) US6350468B1 (tr)
EP (1) EP1037614B1 (tr)
JP (1) JP4615713B2 (tr)
KR (1) KR100509351B1 (tr)
CN (1) CN1147292C (tr)
AR (1) AR014126A1 (tr)
AT (1) ATE254910T1 (tr)
AU (1) AU743090B2 (tr)
BR (1) BR9812803A (tr)
CA (1) CA2315408C (tr)
CZ (1) CZ299181B6 (tr)
DE (1) DE69820108T2 (tr)
DK (1) DK1037614T3 (tr)
ES (1) ES2212391T3 (tr)
HK (1) HK1034897A1 (tr)
HU (1) HU225690B1 (tr)
ID (1) ID26340A (tr)
IT (1) IT1296980B1 (tr)
MY (1) MY121713A (tr)
NO (1) NO329126B1 (tr)
NZ (1) NZ505655A (tr)
PE (1) PE20000512A1 (tr)
PL (1) PL192541B1 (tr)
PT (1) PT1037614E (tr)
TR (1) TR200001761T2 (tr)
WO (1) WO1999030693A2 (tr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
GB0017673D0 (en) * 2000-07-20 2000-09-06 Mw Encap Limited Delivery device
DE60126089T2 (de) * 2000-07-20 2007-11-08 MW Encap Ltd., Livingston Verabreichungssystem
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
US20040105883A1 (en) * 2001-04-17 2004-06-03 Ping Gao Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
US20040105885A1 (en) * 2001-04-17 2004-06-03 Ping Gao Gelatin capsule exhibiting reduced cross-linking
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
US6726809B2 (en) * 2001-09-26 2004-04-27 Albany International Corp. Industrial process fabric
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
AU2003290377A1 (en) * 2003-01-03 2004-07-29 Marton Milankovits Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device
EP1682063A1 (en) * 2003-10-21 2006-07-26 Ambo Innovation LLC Digestible and volume adjustable multi medication delivery device
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
CN100350899C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 冠心丹参双相胶囊及其制备方法
CN100350898C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 复方三七双相胶囊及其制备方法
CN100350900C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 复方降香双相胶囊及其制备方法
US8865197B2 (en) * 2005-09-06 2014-10-21 Israel Oceanographic And Limnological Research Ltd. Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
JP2009511191A (ja) * 2005-10-14 2009-03-19 マイクロドース・テクノロジーズ・インコーポレーテッド 経口投与剤組合せ型医薬パッケージ法
CN100393359C (zh) * 2005-12-13 2008-06-11 济南百诺医药科技开发有限公司 根除幽门螺旋杆菌的多单元组合物
US8784886B2 (en) * 2006-03-09 2014-07-22 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
EP2081550B2 (en) 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
WO2008012621A2 (en) * 2006-07-25 2008-01-31 Vecta, Ltd. Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
CN101513395B (zh) * 2008-02-20 2011-01-12 单宝华 紫杉醇类双层软胶囊口服制剂药物
DE102009001334B4 (de) 2009-03-04 2017-02-23 Stefan Brosig Einfache magensaftresistente Verkapselung, z.B. von Ingwer und anderen empfindlichen Stoffen
CN101607086B (zh) * 2009-07-21 2011-11-02 山西安特生物制药股份有限公司 一种复方铋剂组合物及其制备方法
TWI463998B (zh) * 2009-12-31 2014-12-11 Synmosa Biopharma Corp Amoxicillin and clomycin have a high absorption rate of pharmaceutical ingredients
CN105381524A (zh) * 2010-01-05 2016-03-09 微剂量治疗技术公司 吸入设备和方法
CN102349887A (zh) * 2011-08-02 2012-02-15 天津市嵩锐医药科技有限公司 双氯芬酸钠对乙酰氨基酚胃肠型胶囊药物组合物
ITMI20120350A1 (it) * 2012-03-06 2013-09-07 Ultimate Italia S A S Di Levantino Enrico E C Forma di dosaggio per somministrazione orale di principi attivi
US20160022639A1 (en) * 2014-07-14 2016-01-28 Autotelic Llc Fixed dose combination for pain relief without edema
US9700514B1 (en) * 2014-08-20 2017-07-11 Darren Rubin Single solid oral dosage forms for treating Helicobacter pylori infection and duodenal ulcer disease
CN105106162A (zh) * 2015-08-21 2015-12-02 四川百利药业有限责任公司 一种治疗幽门螺杆菌所引起溃疡的复方片剂及其制备方法
US10772831B2 (en) * 2016-06-22 2020-09-15 University Of Florida Research Foundation, Inc. Pharmaceutical capsules for medication adherence monitoring and methods of forming the same
CN108186968B (zh) * 2018-01-08 2021-07-20 江苏聚荣制药集团有限公司 温胃舒胶囊

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB825480A (en) 1957-07-13 1959-12-16 Johann Carl Pflueger Improvements in or relating to ingestible dry micro-organism preparations and method for producing the same
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
DE2729068A1 (de) * 1977-06-28 1979-01-11 Rainer Dr Med Liedtke Verfahren zur freisetzungssteuerung von arzneimitteln aus kapseln
CA1143287A (en) * 1981-08-11 1983-03-22 William C. Stewart Waterproof edible encapsulation for prophylactic drugs
DK150008C (da) 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4642233A (en) 1982-03-22 1987-02-10 Alza Corporation Gastrointestinal drug delivery system comprising a hydrogel reservoir containing a plurality of tiny pills
FR2524311A1 (fr) * 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
JPS59131355A (ja) 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
JPS60193917A (ja) 1984-03-14 1985-10-02 R P Shiila- Kk 多重構造軟カプセル剤
US4627808A (en) 1985-05-31 1986-12-09 Hughes Raymond J Apparatus for making capsule having plural chambers
US5256684A (en) 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
US4904476A (en) 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4936461A (en) 1986-09-18 1990-06-26 Makiej Jr Walter J Multidose capsules
US4793493A (en) 1986-09-18 1988-12-27 Makiej Jr Walter J Multidose capsules
US4822619A (en) 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5394980A (en) 1987-06-30 1995-03-07 Tsai; Min H. Multicompartment mixing capsule
WO1989003219A1 (en) * 1987-10-12 1989-04-20 Borody Thomas J Improved method for treatment of gastrointestinal disorders
US5192752A (en) 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
US5582837A (en) 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5472695A (en) 1992-06-25 1995-12-05 Technion Research And Development Foundation Ltd. Therapeutic application of a thyme extract and in - vitro methods for inhibiting the growth and urease activity of helicobacter pylori
US5310555A (en) 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
ES2157253T3 (es) * 1993-02-26 2001-08-16 Procter & Gamble Forma de dosificacion de bisacodilo.
WO1996010996A1 (en) 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US5560912A (en) 1994-06-27 1996-10-01 Technion Research & Development Foundation Ltd. Method for inhibiting growth of helicobacter pylori
AUPM695294A0 (en) 1994-07-20 1994-08-11 Borody, Thomas Julius Improved combination therapy dose unit

Also Published As

Publication number Publication date
JP2002508312A (ja) 2002-03-19
CN1285741A (zh) 2001-02-28
ITMI972788A1 (it) 1999-06-17
CA2315408A1 (en) 1999-06-24
PL192541B1 (pl) 2006-11-30
CA2315408C (en) 2005-05-24
US6350468B1 (en) 2002-02-26
HUP0100095A2 (hu) 2001-06-28
DK1037614T3 (da) 2004-04-05
EP1037614A2 (en) 2000-09-27
JP4615713B2 (ja) 2011-01-19
DE69820108D1 (de) 2004-01-08
HU225690B1 (en) 2007-06-28
WO1999030693A3 (en) 1999-09-02
NO20003159L (no) 2000-08-16
KR100509351B1 (ko) 2005-08-22
WO1999030693A2 (en) 1999-06-24
PT1037614E (pt) 2004-04-30
BR9812803A (pt) 2000-10-03
NZ505655A (en) 2003-09-26
ATE254910T1 (de) 2003-12-15
HK1034897A1 (en) 2001-11-09
PL341737A1 (en) 2001-05-07
IT1296980B1 (it) 1999-08-03
ES2212391T3 (es) 2004-07-16
KR20010033244A (ko) 2001-04-25
CZ299181B6 (cs) 2008-05-14
AU743090B2 (en) 2002-01-17
DE69820108T2 (de) 2004-09-09
CZ20002231A3 (cs) 2000-11-15
EP1037614B1 (en) 2003-11-26
NO329126B1 (no) 2010-08-30
PE20000512A1 (es) 2000-06-13
ID26340A (id) 2000-12-14
NO20003159D0 (no) 2000-06-16
CN1147292C (zh) 2004-04-28
MY121713A (en) 2006-02-28
AU2413599A (en) 1999-07-05
HUP0100095A3 (en) 2001-12-28
AR014126A1 (es) 2001-02-07

Similar Documents

Publication Publication Date Title
TR200001761T2 (tr) Çoklu terapilerde aktif esasların tatbiki için bir çift kapsül.
HUP9801283A2 (hu) Tomoxetin alkalmazása figyelemhiány/hiperaktivitás betegség kezelésére alkalmas gyógyszerkészítmény előállítására
Gereklioglu et al. Medication adherence to oral iron therapy in patients with iron deficiency anemia
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
ATE340563T1 (de) DOSIERUNGSFORM DES TYPS ßHÜLLE UND KERNß MIT EINER WIRKSTOFFFREISETZUNG, DIE SICH DER NULLTEN ORDNUNG ANNÄHERT
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
SE0003449D0 (sv) Anticancer compositions
ES2124303T3 (es) Formas de dosificacion de farmacos orales de liberacion retardada a base de hidroxietilcelulosa.
HUP0203623A2 (hu) Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
BR0015188A (pt) Composições farmacêuticas
HUP0102521A2 (hu) Sztilbénszármazékot és platina koordinációs vegyületet tartalmazó daganatellenes szer
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
TR200202737T2 (tr) Aktif katkı maddeleri ihtiva eden şekerleme ürünleri.
Fenichel et al. Combination products as first-line pharmacotherapy
HUP0104476A2 (hu) Hidroxi-propil-mutil-cellulóz kapszulákban formázott gyógyszerkészítmények
TR200101928T2 (tr) Geliştirilmiş kararlılığa sahip bileşimler
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
Lichtenstein et al. Mesalazine granules 1.5 g once‐daily maintain remission in patients with ulcerative colitis who switch from other 5‐ASA formulations: a pooled analysis from two randomised controlled trials
Prajapati et al. Critical analysis of cardiovascular and central nervous system fixed dose combinations available in indian market
FR2796840B1 (fr) Comprimes faiblement doses et procede de preparation
AR042308A1 (es) Medicamento de administracion transdermica y transmucosica con absorcion mejorada de principios activos
DZ3103A1 (fr) Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation.
DK0595110T3 (da) Indhylningsmateriale til oralt administrerbare former
TR199901237T2 (tr) Bir tienilsiklohegzilamin türevinin tedavide yeni uygulamasi.